Influence of genetic variations in TLR4 and TIRAP/Mal on the course of sepsis and pneumonia and cytokine release: an observational study in three cohorts.
暂无分享,去创建一个
M. Netea | D. Schwartz | P. Schlag | E. Latz | B. Ferwerda | B. Kullberg | J. V. D. van der Meer | K. Zacharowski | R. Schumann | E. Lorenz | E. Giamarellos‐Bourboulis | D. Oh | M. Mouktaroudi | A. Koch | L. Hamann | O. Kumpf | C. Routsi | Chryssanthi Skalioti | Jos W M van der Meer
[1] L. Oskam,et al. Low frequency of the TIRAP S180L polymorphism in Africa, and its potential role in malaria, sepsis, and leprosy , 2009, BMC Medical Genetics.
[2] Lutz Hamann,et al. Functional and genetic evidence that the Mal/TIRAP allele variant 180L has been selected by providing protection against septic shock , 2009, Proceedings of the National Academy of Sciences.
[3] T. van der Poll,et al. Immunosuppression associated with interleukin-1R-associated-kinase-M upregulation predicts mortality in Gram-negative sepsis (melioidosis) , 2009, Critical care medicine.
[4] Mauricio Valencia,et al. Ventilator-associated pneumonia , 2009, Current opinion in critical care.
[5] R. Salomão,et al. TLR signaling pathway in patients with sepsis. , 2008, Shock.
[6] G. Angelini,et al. Inflammatory response and cardioprotection during open‐heart surgery: the importance of anaesthetics , 2008, British journal of pharmacology.
[7] R. Medzhitov. Recognition of microorganisms and activation of the immune response , 2007, Nature.
[8] M. Netea,et al. TLR4 polymorphisms, infectious diseases, and evolutionary pressure during migration of modern humans , 2007, Proceedings of the National Academy of Sciences.
[9] S. Akira,et al. Role for MyD88-Independent, TRIF Pathway in Lipid A/TLR4-Induced Endotoxin Tolerance1 , 2007, The Journal of Immunology.
[10] J. Cavaillon,et al. Stress molecules in sepsis and systemic inflammatory response syndrome , 2007, FEBS letters.
[11] Thomas C. Mitchell,et al. The Vaccine Adjuvant Monophosphoryl Lipid A as a TRIF-Biased Agonist of TLR4 , 2007, Science.
[12] D. Remick,et al. Pathophysiology of sepsis. , 2007, The American journal of pathology.
[13] Giorgio Sirugo,et al. A Mal functional variant is associated with protection against invasive pneumococcal disease, bacteremia, malaria and tuberculosis , 2007, Nature Genetics.
[14] S. Calvano,et al. Response to systemic endotoxemia among humans bearing polymorphisms of the Toll-like receptor 4 (hTLR4). , 2006, Clinical immunology.
[15] L. Zhao,et al. A polymorphism in Toll-interleukin 1 receptor domain containing adaptor protein is associated with susceptibility to meningeal tuberculosis. , 2006, The Journal of infectious diseases.
[16] R. Medzhitov,et al. Phosphoinositide-Mediated Adaptor Recruitment Controls Toll-like Receptor Signaling , 2006, Cell.
[17] C. Roussos,et al. Early apoptosis of blood monocytes in the septic host: is it a mechanism of protection in the event of septic shock? , 2006, Critical care.
[18] S. Bornstein,et al. Toll-like receptor 4 plays a crucial role in the immune-adrenal response to systemic inflammatory response syndrome. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[19] S. Akira,et al. Pathogen Recognition and Innate Immunity , 2006, Cell.
[20] P. Schlag,et al. PRE- AND POSTOPERATIVE CYTOKINE RELEASE AFTER IN VITRO WHOLE BLOOD LIPOPOLYSACCHARIDE STIMULATION AND FREQUENT TOLL-LIKE RECEPTOR 4 POLYMORPHISMS , 2006, Shock.
[21] C. Roussos,et al. Soluble triggering receptor expressed on myeloid cells 1 as an anti-inflammatory mediator in sepsis. , 2006, Intensive care medicine.
[22] S. Zakynthinos,et al. Does soluble triggering receptor expressed on myeloid cells‐1 play any role in the pathogenesis of septic shock? , 2005, Clinical and experimental immunology.
[23] E. Abraham,et al. GENETIC POLYMORPHISMS AND SEPSIS , 2005, Shock.
[24] L. Jacobs,et al. Functional consequences of the Asp299Gly Toll-like receptor-4 polymorphism. , 2005, Cytokine.
[25] R. Schumann,et al. Single nucleotide polymorphisms of Toll-like receptors and susceptibility to infectious disease. , 2005, The Lancet. Infectious diseases.
[26] M. David,et al. INHIBITION OF LIPOPOLYSACCHARIDE-INDUCED INTERFERON REGULATORY FACTOR 3 ACTIVATION AND PROTECTION FROM SEPTIC SHOCK BY HYDROXYSTILBENES , 2004, Shock.
[27] S. le Cessie,et al. TNF-alpha promoter, Nod2 and toll-like receptor-4 polymorphisms and the in vivo and ex vivo response to endotoxin. , 2004, Cytokine.
[28] R. Schumann,et al. Rapid and inexpensive real-time PCR for genotyping functional polymorphisms within the Toll-like receptor -2, -4, and -9 genes. , 2004, Journal of immunological methods.
[29] T. Albertson,et al. Genomic polymorphisms in sepsis , 2004, Critical care medicine.
[30] B. Beutler. Innate immunity: an overview. , 2004, Molecular immunology.
[31] M. Fenton,et al. TLRs: differential adapter utilization by toll-like receptors mediates TLR-specific patterns of gene expression. , 2003, Molecular interventions.
[32] K. Walley,et al. Genetic polymorphisms in sepsis and septic shock: role in prognosis and potential for therapy. , 2003, Chest.
[33] B. Beutler,et al. Assay of locus-specific genetic load implicates rare Toll-like receptor 4 mutations in meningococcal susceptibility , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[34] M. Netea,et al. Proinflammatory cytokines and sepsis syndrome: not enough, or too much of a good thing? , 2003, Trends in immunology.
[35] Mitchell M. Levy,et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference , 2003, Intensive Care Medicine.
[36] S. Msika,et al. Risk factors for postoperative infectious complications in noncolorectal abdominal surgery: a multivariate analysis based on a prospective multicenter study of 4718 patients. , 2003, Archives of surgery.
[37] S. Calvano,et al. Human toll-like receptor 4 mutations but not CD14 polymorphisms are associated with an increased risk of gram-negative infections. , 2002, The Journal of infectious diseases.
[38] D. Schwartz,et al. Relevance of mutations in the TLR4 receptor in patients with gram-negative septic shock. , 2002, Archives of internal medicine.
[39] A. Waage,et al. Inflammatory Response After Open Heart Surgery: Release of Heat-Shock Protein 70 and Signaling Through Toll-Like Receptor-4 , 2002, Circulation.
[40] Dirk E. Smith,et al. Mal (MyD88-adapter-like) is required for Toll-like receptor-4 signal transduction , 2001, Nature.
[41] C. Cannings,et al. A functional polymorphism of toll-like receptor 4 is not associated with likelihood or severity of meningococcal disease. , 2001, The Journal of infectious diseases.
[42] D. Schwartz,et al. Determination of the TLR4 genotype using allele-specific PCR. , 2001, BioTechniques.
[43] J. Parrillo. Pathogenetic mechanisms of septic shock. , 1993, The New England journal of medicine.
[44] P. Andersen,et al. Genetic and environmental influences on premature death in adult adoptees. , 1988, The New England journal of medicine.
[45] M. McCarron,et al. Septic Shock , 1964, International anesthesiology clinics.
[46] 戴生明. “proinflammatory cytokines”不宜翻译为“前炎症细胞因子” , 2010 .